RT Journal Article
SR Electronic
T1 Developing a model for predicting impairing physical symptoms in children 3 months after a SARS-CoV-2 PCR-test: The CLoCk Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.01.22273117
DO 10.1101/2022.04.01.22273117
A1 Nugawela, Manjula D
A1 Stephenson, Terence
A1 Shafran, Roz
A1 De Stavola, Bianca L
A1 Ladhani, Shamez N
A1 Simmons, Ruth
A1 McOwatt, Kelsey
A1 Rojas, Natalia
A1 Cheung, Emily Y
A1 Ford, Tamsin
A1 Heyman, Isobel
A1 Crawley, Esther
A1 Pinto Pereira, Snehal M
YR 2022
UL http://medrxiv.org/content/early/2022/04/05/2022.04.01.22273117.abstract
AB Importance Predictive models can help identify SARS-CoV-2 patients at greatest risk of post-COVID sequelae and direct them towards appropriate care.Objective To develop and internally validate a model to predict children and young people most likely to experience at least one impairing physical symptom 3 months after a SARS-CoV-2 PCR-test and to determine whether the impact of these predictors differed by SARS-CoV-2 infection status.Design Potential pre-specified predictors included: SARS-CoV-2 status, sex, age, ethnicity, deprivation, quality of life/functioning (5 EQ-5D-Y items), physical and mental health, and loneliness (all prior to SARS-CoV-2 testing), and number of physical symptoms at testing. Logistic regression was used to develop the model. Model performance was assessed using calibration and discrimination measures; internal validation was performed via bootstrapping; the final model was adjusted for overfitting.Setting National cohort study of SARS-CoV-2 PCR-positive and PCR-negative participants matched according to age, sex, and geographical area.Participants Children and young people aged 11-17 years who were tested for SARS-CoV-2 infection in England, January to March 2021.Main outcome measure one or more physical symptom 3 months after initial PCR-testing which affected physical, mental or social well-being and interfered with daily living.Results A total of 50,836 children and young people were approached; 7,096 (3,227 test-positives, 3,869 test-negatives) who completed a questionnaire 3 months after their PCR-test were included. 39.6% (1,279/3,227) of SAR-CoV-2 PCR-positives and 30.6% (1,184/3,869) of SAR-CoV-2 PCR-negatives had at least one impairing physical symptom 3 months post-test. The final model contained predictors: SARS-COV-2 status, number of symptoms at testing, sex, age, ethnicity, self-rated physical and mental health, feelings of loneliness and four EQ-5D-Y items before testing. Internal validation showed minimal overfitting with excellent calibration and discrimination measures (optimism adjusted calibration slope:0.97527; C-statistic:0.83640).Conclusions and relevance We developed a risk prediction equation to identify those most at risk of experiencing at least one impairing physical symptom 3 months after a SARS-CoV-2 PCR-test which could serve as a useful triage and management tool for children and young people during the ongoing pandemic. External validation is required before large-scale implementation.Question Which children have impairing physical symptoms during the COVID-19 pandemic?Findings Using data from a large national matched cohort study in children and young people (CYP) aged 11-17 years (N=7,096), we developed a prediction model for experiencing at least one impairing physical symptom 3 months after testing for SARS-COV-2. Our model had excellent predictive ability, calibration and discrimination; we used it to produce a risk estimation calculator.Meaning Our developed risk calculator could serve as a useful tool in the early identification and management of CYP at risk of persisting physical symptoms in the context of the COVID-19 pandemic.Competing Interest StatementConflicts of interest: Terence Stephenson is Chair of the Health Research Authority and therefore recused himself from the research ethics application. All other authors declare no competing interests.Funding StatementFunded by The Department of Health and Social Care, in their capacity as the National Institute for Health Research (NIHR), and by UK Research & Innovation (UKRI) who have awarded funding grant number COVLT0022. All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. SMPP is supported by a UK Medical Research Council Career Development Award (reference: MR/P020372/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We use data from the CLoCk study: a national cohort study of SARS-CoV-2 PCR-positive CYP aged 11-17 years living in England who were matched at study invitation, on month of test, age, sex, and geographical area, to SARS-CoV-2 test-negative CYP selected from the national testing database at Public Health England (now UKHSA).20 The study was approved by Yorkshire and the Humber South Yorkshire Research Ethics Committee (reference: 21/YH/0060). 20.Stephenson T, Shafran R, De Stavola B, et al. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open. Aug 26 2021;11(8):e052838. doi:10.1136/bmjopen-2021-052838I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript